XML 15 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Sep. 30, 2017
Dec. 31, 2016
Assets    
Cash and cash equivalents $ 350 $ 359
Accounts receivable, net of allowance for doubtful accounts of $286 and $265 as of September 30, 2017 and December 31, 2016, respectively 960 926
Inventories 100 82
Prepaid expenses and other current assets 134 164
Total current assets 1,544 1,531
Property, plant and equipment, net 1,097 1,029
Goodwill 6,164 6,000
Intangible assets, net 1,029 949
Investment in equity method investees 459 443
Other assets 146 148
Total assets 10,439 10,100
Liabilities and Stockholders' Equity    
Accounts payable and accrued expenses 1,047 975
Current portion of long-term debt 5 6
Total current liabilities 1,052 981
Long-term debt 3,759 3,728
Other liabilities 722 654
Commitments and contingencies
Redeemable noncontrolling interest 78 77
Quest Diagnostics stockholders’ equity:    
Common stock, par value $0.01 per share; 600 shares authorized as of both September 30, 2017 and December 31, 2016; 216 shares issued as of both September 30, 2017 and December 31, 2016 2 2
Additional paid-in capital 2,585 2,545
Retained earnings 6,946 6,613
Accumulated other comprehensive loss (48) (72)
Treasury stock, at cost; 80 shares and 79 shares as of September 30, 2017 and December 31, 2016, respectively (4,691) (4,460)
Total Quest Diagnostics stockholders' equity 4,794 4,628
Noncontrolling interests 34 32
Total stockholders' equity 4,828 4,660
Total liabilities and stockholders' equity $ 10,439 $ 10,100